The clinical link of the integrin‐FAK axis was probed by conducting bioinformatic and histological analyses of both The Cancer Genome Atlas (TCGA) and local CRC patient cohorts with respect to their genomic dysregulations, subcellular distribution/activation across tumor stages and metastatic lesions. This evidence concerns the gene PTK2 and colorectal carcinoma.